Literature DB >> 28693181

Distinct DNA methylation alterations are associated with cribriform architecture and intraductal carcinoma in Gleason pattern 4 prostate tumors.

Ekaterina Olkhov-Mitsel1,2, Farshid Siadat3, Ken Kron4, Liyang Liu1,2, Andrea J Savio1,2, John Trachtenberg5, Neil Fleshner5, Theodorus van der Kwast2,6, Bharati Bapat1,2,6.   

Abstract

The aim of the present study was to explore DNA methylation aberrations in association with cribriform architecture and intraductal carcinoma (IDC) of the prostate, as there is robust evidence that these morphological features are associated with aggressive disease and have significant clinical implications. Herein, the associations of a panel of seven known prognostic DNA methylation biomarkers with cribriform and IDC features were examined in a series of 91 Gleason pattern (GP) 4 tumors derived from Gleason score 7 radical prostatectomies. Gene specific DNA methylation was compared between cribriform and/or IDC positive vs. negative cases, and in association with clinicopathological features, using Chi square and Mann-Whitney U tests. DNA methylation of the adenomatous polyposis coli, Ras association domain family member 1 and T-box 15 genes was significantly elevated in GP4 tumors with cribriform and/or IDC features compared with negative cases (P=0.045, P=0.007 and P=0.013, respectively). To the best of our knowledge, this provides the first evidence for an association between cribriform and/or IDC and methylation biomarkers, and warrants further investigation of additional DNA methylation events in association with various architectural patterns in prostate cancer.

Entities:  

Keywords:  DNA methylation; Gleason pattern; MethyLight; biomarker; cribriform architecture; intraductal carcinoma; pathology; prostate cancer

Year:  2017        PMID: 28693181      PMCID: PMC5494878          DOI: 10.3892/ol.2017.6140

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  34 in total

1.  Microarray analysis detects novel Pax3 downstream target genes.

Authors:  C S Mayanil; D George; L Freilich; E J Miljan; B Mania-Farnell; D G McLone; E G Bremer
Journal:  J Biol Chem       Date:  2001-10-05       Impact factor: 5.157

2.  Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings.

Authors:  Brian D Robinson; Jonathan I Epstein
Journal:  J Urol       Date:  2010-08-17       Impact factor: 7.450

Review 3.  Prognostic prostate tissue biomarkers of potential clinical use.

Authors:  Theodorus H Van der Kwast
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

4.  Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort.

Authors:  Dominique Trudel; Michelle R Downes; Jenna Sykes; Ken J Kron; John Trachtenberg; Theodorus H van der Kwast
Journal:  Eur J Cancer       Date:  2014-04-03       Impact factor: 9.162

5.  Association of tissue promoter methylation levels of APC, TGFβ2, HOXD3 and RASSF1A with prostate cancer progression.

Authors:  Liyang Liu; Ken J Kron; Vaijayanti V Pethe; Nino Demetrashvili; Michael E Nesbitt; John Trachtenberg; Hilmi Ozcelik; Neil E Fleshner; Laurent Briollais; Theodorus H van der Kwast; Bharati Bapat
Journal:  Int J Cancer       Date:  2011-04-13       Impact factor: 7.396

6.  Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer.

Authors:  Charlotte F Kweldam; Mark F Wildhagen; Ewout W Steyerberg; Chris H Bangma; Theodorus H van der Kwast; Geert J L H van Leenders
Journal:  Mod Pathol       Date:  2014-09-05       Impact factor: 7.842

7.  Classification of prostatic carcinomas.

Authors:  D F Gleason
Journal:  Cancer Chemother Rep       Date:  1966-03

8.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

Review 9.  Epigenetics in cancer.

Authors:  Shikhar Sharma; Theresa K Kelly; Peter A Jones
Journal:  Carcinogenesis       Date:  2009-09-13       Impact factor: 4.944

10.  Architectural heterogeneity and cribriform pattern predict adverse clinical outcome for Gleason grade 4 prostatic adenocarcinoma.

Authors:  Fei Dong; Ping Yang; Chaofu Wang; Shulin Wu; Yu Xiao; W Scott McDougal; Robert H Young; Chin-Lee Wu
Journal:  Am J Surg Pathol       Date:  2013-12       Impact factor: 6.394

View more
  4 in total

Review 1.  Cribriform Patterned Lesions in the Prostate Gland with Emphasis on Differential Diagnosis and Clinical Significance.

Authors:  Maria Destouni; Andreas C Lazaris; Vasiliki Tzelepi
Journal:  Cancers (Basel)       Date:  2022-06-21       Impact factor: 6.575

2.  Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate.

Authors:  Habiba Elfandy; Joshua Armenia; Filippo Pederzoli; Eli Pullman; Nelma Pertega-Gomes; Nikolaus Schultz; Kartik Viswanathan; Aram Vosoughi; Mirjam Blattner; Konrad H Stopsack; Giorgia Zadra; Kathryn L Penney; Juan Miguel Mosquera; Svitlana Tyekucheva; Lorelei A Mucci; Christopher Barbieri; Massimo Loda
Journal:  Mol Cancer Res       Date:  2018-10-17       Impact factor: 5.852

Review 3.  Cribriform Prostate Cancer: Clinical Pathologic and Molecular Considerations.

Authors:  Amanda B Hesterberg; Jennifer B Gordetsky; Paula J Hurley
Journal:  Urology       Date:  2021-05-28       Impact factor: 2.633

Review 4.  Intraductal Carcinoma of the Prostate as a Cause of Prostate Cancer Metastasis: A Molecular Portrait.

Authors:  Helen Pantazopoulos; Mame-Kany Diop; Andrée-Anne Grosset; Frédérique Rouleau-Gagné; Afnan Al-Saleh; Teodora Boblea; Dominique Trudel
Journal:  Cancers (Basel)       Date:  2022-02-06       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.